U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H31N3O4
Molecular Weight 521.6062
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TD-5471

SMILES

COC1=C(C=C(NC2=CC=C(CCNC[C@H](O)C3=CC=C(O)C4=C3C=CC(=O)N4)C=C2)C=C1)C5=CC=CC=C5

InChI

InChIKey=LGFPFBZHAODPHC-LJAQVGFWSA-N
InChI=1S/C32H31N3O4/c1-39-30-15-11-24(19-27(30)22-5-3-2-4-6-22)34-23-9-7-21(8-10-23)17-18-33-20-29(37)25-12-14-28(36)32-26(25)13-16-31(38)35-32/h2-16,19,29,33-34,36-37H,17-18,20H2,1H3,(H,35,38)/t29-/m0/s1

HIDE SMILES / InChI

Molecular Formula C32H31N3O4
Molecular Weight 521.6062
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:56:17 GMT 2023
Edited
by admin
on Sat Dec 16 11:56:17 GMT 2023
Record UNII
M37E3NE7QB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TD-5471
Code English
2(1H)-QUINOLINONE, 8-HYDROXY-5-((1R)-1-HYDROXY-2-((2-(4-((6-METHOXY(1,1'-BIPHENYL)-3-YL)AMINO)PHENYL)ETHYL)AMINO)ETHYL)-
Systematic Name English
TD5471
Code English
N-(2-(4-((3-PHENYL-4-METHOXYPHENYL)AMINO)PHENYL)ETHYL)-(R)-2-HYDROXY-2-(8-HYDROXY-1,2-DIHYDRO-2-OXOQUINOLIN-5-YL)ETHYLAMINE
Systematic Name English
8-HYDROXY-5-((1R)-1-HYDROXY-2-((2-(4-((6-METHOXY(1,1'-BIPHENYL)-3-YL)AMINO)PHENYL)ETHYL)AMINO)ETHYL)-2(1H)-QUINOLINONE
Systematic Name English
Code System Code Type Description
PUBCHEM
9871386
Created by admin on Sat Dec 16 11:56:17 GMT 2023 , Edited by admin on Sat Dec 16 11:56:17 GMT 2023
PRIMARY
CAS
530084-87-8
Created by admin on Sat Dec 16 11:56:17 GMT 2023 , Edited by admin on Sat Dec 16 11:56:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID30432118
Created by admin on Sat Dec 16 11:56:17 GMT 2023 , Edited by admin on Sat Dec 16 11:56:17 GMT 2023
PRIMARY
FDA UNII
M37E3NE7QB
Created by admin on Sat Dec 16 11:56:17 GMT 2023 , Edited by admin on Sat Dec 16 11:56:17 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
TD-5471 (25), a potent and selective full agonist of the human .BETA.2-adrenoceptor, was identified as the most promising agent. It is potent, with slow onset in an in vitro guinea pig trachea model and shows a dose-dependent and long duration of action in an in vivo guinea pig model of bronchoprotection. TD-5471 is structurally differentiated from milveterol and its long duration of action is consistent with a correlation with hydrophobicity observed in other long-acting .BETA.2-agonist discovery programs.
ACTIVE MOIETY
Originator: Theravance Biopharma; Mechanism of Action: Beta 2 adrenergic receptor agonist; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes; Highest Development Phase: No development reported for Asthma, Chronic obstructive pulmonary disease; Most Recent Event: 16 May 2016 Chemical information added